We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Presents Virtual Showcase of Laboratory Solutions at EUROMEDLAB 2022

By Carolyn Moody, RN - News Editor
Posted on 11 Apr 2022

To make up for its physical absence at the hybrid EUROMEDLAB 2022 event, Beckman Coulter, Inc. More...

(Brea, CA, USA) presented its instruments and workflow solutions for laboratories of all sizes through its immersive, 3D virtual product showcase.

Beckman Coulter’s virtual showcase displayed its line of instruments and automation specially designed to elevate the performance of low, medium, and high-volume laboratories. This included the DxA 5000 Fit workflow automation system that fundamentally improves lab workflow by making intelligent automation accessible to fit the needs of small- and mid-sized labs. The DxA 5000 Fit drives speed and accuracy, all while maintaining a small footprint. It eliminates up to 80% of the manual steps associated with processing a patient sample, allowing labs to keep their focus on what matters most: patient care. The DxA 5000 Fit can be designed in unique configurations that allow the automation system to fit any lab’s needs. With flexible line customization and a compact footprint, the DxA 5000 Fit can accommodate different workloads and footprints while optimizing laboratory space.

Beckman Coulter’s virtual showcase also included the DxU Iris Workcell fully automated system that streamlines urinalysis workflow and reduces manual reviews to 4%. The DxU Iris Workcell pairs the DxU 850m Iris or DxU 840m Iris urine microscopy analyzer with the Arkray AUTION MAX 4030 urine chemistry analyzer to create a scalable, fully automated urinalysis solution. The workcell was developed with proprietary Digital Flow Morphology technology with Auto-Particle Recognition (APR) Software to enable laboratories to deliver standardized results using artificial intelligence (AI). This industry-leading technology isolates, identifies, and characterizes urine particles to provide immediate, accurate, and reproducible results verified directly on the screen.

Also on display at Beckman Coulter’s virtual showcase was the DxH 560 AL hematology analyzer that helps save time and resources, eliminate manual intervention and deliver high-quality results, even for difficult-draw patient groups. The multi-tube, compact hematology analyzer allows labs to load and go up to 50 samples with on-the-fly continuous loading more than twice the capacity compared to the closest competitor. Among others, Beckman Coulter provided a glimpse of its MicroScan microbiology solutions in 3D that provide first-time accuracy with direct MIC for trusted detection of emerging and critical antimicrobial resistance. The company displayed its microbiology panels, systems and analyzers that can improve workflow by automating and standardizing all core aspects of specimen processing for even the most challenging samples. Viewers experienced how patient care can be enhanced with direct MIC methods to provide trusted detection of emerging and critical antimicrobial resistance, while organizing data and managing results with the company’s easy-to-use LabPro software suite.

Related Links:
Beckman Coulter, Inc.


New
Gold Member
Latex Test
SLE-Latex Test
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
TRAb Immunoassay
Chorus TRAb
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.